MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Agios Pharmaceuticals Company Profile (NASDAQ:AGIO)

Consensus Ratings for Agios Pharmaceuticals (NASDAQ:AGIO) (?)
Ratings Breakdown: 6 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $115.17 (27.93% upside)

Analysts' Ratings History for Agios Pharmaceuticals (NASDAQ:AGIO)
Show:
DateFirmActionRatingPrice TargetActions
8/7/2015Canaccord GenuityReiterated RatingHold$93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Roth CapitalReiterated RatingHold$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Northland SecuritiesInitiated CoverageOutperform$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015DesjardinsUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Canaccord GenuityLower Price TargetHold$103.00 -> $93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Citigroup Inc.Initiated CoverageNeutral$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015MLV & Co.Initiated CoverageBuy$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Canaccord GenuityDowngradeBuy -> Hold$163.00 -> $103.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015Citigroup Inc.Set Price TargetHold$137.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015MLV & Co.Boost Price TargetBuy$123.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Canaccord GenuitySet Price TargetBuy$163.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Citigroup Inc.DowngradeBuy -> Neutral$93.00 -> $137.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Roth CapitalInitiated CoverageNeutral$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014MLV & Co.Initiated CoverageBuy$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014JPMorgan Chase & Co.DowngradeOverweight -> Neutral$60.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2014Canaccord GenuityReiterated RatingBuy$97.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014Canaccord GenuityInitiated CoverageBuy$97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2014Citigroup Inc.Initiated CoverageBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2014JPMorgan Chase & Co.Reiterated RatingOverweight$55.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2014Leerink SwannBoost Price Target$51.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$40.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2014JPMorgan Chase & Co.Boost Price Target$35.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2014Leerink SwannBoost Price Target$38.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha